APP and Hyperglycemia: Abnormal accumulation of advanced glycation end products (AGEs) due to hyperglycaemia has been demonstrated to increase the production of reactive oxygen species (ROS), which in turn stimulates downstream APP-related pathway, Aβ production [26], NAD+-dependent deacetylase sirtuin 1 (Sirt1) and glucose regulatory protein 78 (GRP78).